Ebalzotan

From WikiMD's Wellness Encyclopedia

Ebalzotan is a serotonin 5-HT1A receptor agonist that was under development by Eisai Co. for the treatment of anxiety and depression. It reached Phase II clinical trials for these indications but was discontinued.

History[edit | edit source]

Ebalzotan was first developed by the Japanese pharmaceutical company Eisai Co. The drug was designed to act as a serotonin 5-HT1A receptor agonist, a type of drug that has been used in the treatment of various psychiatric and neurological disorders.

Mechanism of Action[edit | edit source]

Ebalzotan works by binding to and activating the 5-HT1A receptors in the brain. These receptors are a type of G protein-coupled receptor that are activated by the neurotransmitter serotonin. By activating these receptors, ebalzotan can increase the levels of serotonin in the brain, which can help to alleviate symptoms of anxiety and depression.

Clinical Trials[edit | edit source]

Ebalzotan underwent Phase II clinical trials for the treatment of anxiety and depression. However, the development of the drug was discontinued for unknown reasons.

See Also[edit | edit source]

Ebalzotan Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD